These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 9298877)

  • 1. Neuroendocrine differentiation in 32 cases of so-called sclerosing hemangioma of the lung: identified by immunohistochemical and ultrastructural study.
    Xu HM; Li WH; Hou N; Zhang SG; Li HF; Wang SQ; Yu ZY; Li ZJ; Zeng MY; Zhu GM
    Am J Surg Pathol; 1997 Sep; 21(9):1013-22. PubMed ID: 9298877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A benign neuroendocrine tumor of the lung: study on the origin of the so-called sclerosing hemangioma of the lung].
    Li WH; Xu HM; Li HF
    Zhonghua Bing Li Xue Za Zhi; 1994 Apr; 23(2):69-72. PubMed ID: 8082241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic neuroendocrine tumors to the thyroid gland mimicking medullary carcinoma: a pathologic and immunohistochemical study of six cases.
    Matias-Guiu X; LaGuette J; Puras-Gil AM; Rosai J
    Am J Surg Pathol; 1997 Jul; 21(7):754-62. PubMed ID: 9236831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical and ultrastructural markers suggest different origins for cuboidal and polygonal cells in pulmonary sclerosing hemangioma.
    Wang E; Lin D; Wang Y; Wu G; Yuan X
    Hum Pathol; 2004 Apr; 35(4):503-8. PubMed ID: 15116333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual features of metastatic atypical carcinoid of the larynx.
    Alujević A; Jurić G; Separović R; Kruslin B
    Eur Arch Otorhinolaryngol; 1998; 255(6):318-21. PubMed ID: 9693930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraskeletal myxoid chondrosarcoma: a light microscopic, immunohistochemical, ultrastructural and immuno-ultrastructural study indicating neuroendocrine differentiation.
    Goh YW; Spagnolo DV; Platten M; Caterina P; Fisher C; Oliveira AM; Nascimento AG
    Histopathology; 2001 Nov; 39(5):514-24. PubMed ID: 11737310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium.
    Devouassoux-Shisheboran M; Hayashi T; Linnoila RI; Koss MN; Travis WD
    Am J Surg Pathol; 2000 Jul; 24(7):906-16. PubMed ID: 10895813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary pneumocytoma of the lung. An immunohistochemical and electron microscopic study.
    Heikkilä P; Salminen US
    Pathol Res Pract; 1994 Feb; 190(2):194-200. PubMed ID: 8058573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Spindle cell carcinoma of breast with neuroendocrine differentiation].
    Ding HY; Gao LX
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):13-7. PubMed ID: 16608642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical carcinoid tumor of the lung, associated with giant-cell transformation in bone metastasis.
    Tsutsumi Y; Yazaki K; Yoshioka K
    Acta Pathol Jpn; 1990 Aug; 40(8):609-15. PubMed ID: 1700576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two different types of carcinoid tumors of the lung: immunohistochemical and ultrastructural investigation and their histogenetic consideration.
    Min KW
    Ultrastruct Pathol; 2013 Feb; 37(1):23-35. PubMed ID: 23383615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
    Graziano SL; Tatum AH; Newman NB; Oler A; Kohman LJ; Veit LJ; Gamble GP; Coleman MJ; Barmada S; O'Lear S
    Cancer Res; 1994 Jun; 54(11):2908-13. PubMed ID: 8187076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of thyroid transcription factor-1 and other markers in sclerosing hemangioma of the lung.
    Illei PB; Rosai J; Klimstra DS
    Arch Pathol Lab Med; 2001 Oct; 125(10):1335-9. PubMed ID: 11570910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of neuroendocrine differentiation in non-small cell lung cancer. The LCSG experience.
    Linnoila RI; Piantadosi S; Ruckdeschel JC
    Chest; 1994 Dec; 106(6 Suppl):367S-371S. PubMed ID: 7988266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
    Kasprzak A; Zabel M; Biczysko W
    Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pigmented pulmonary carcinoid tumor. An immunohistochemical and ultrastructural study.
    Gal AA; Koss MN; Hochholzer L; DeRose PB; Cohen C
    Arch Pathol Lab Med; 1993 Aug; 117(8):832-6. PubMed ID: 7688214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchopulmonary carcinoid tumors--a significant diagnostic problem.
    Kedra P; Jeleń M; Szkudlarek-Gruszczyńska T; Leśkow E
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():146-61. PubMed ID: 9337533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
    Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
    Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. So-called sclerosing hemangioma of the lung. An immunohistochemical, histochemical and ultrastructural study.
    Fukayama M; Koike M
    Acta Pathol Jpn; 1988 May; 38(5):627-42. PubMed ID: 2463730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas.
    Linnoila RI; Mulshine JL; Steinberg SM; Funa K; Matthews MJ; Cotelingam JD; Gazdar AF
    Am J Clin Pathol; 1988 Dec; 90(6):641-52. PubMed ID: 2848408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.